STAMPEDE: Does abiraterone (with or without enzalutamide) benefit men with prostate cancer?
The STAMPEDE trial presents clear evidence that abiraterone benefits people living with prostate cancer both at the early stages and once the cancer has already spread.
▶︎
Rob's prostate cancer story and successful treatment with abiraterone
▶︎
16 Years: Surviving Metastatic #ProstateCancer | Joel Nowak, CEO of @Cancer ABCs | #PCRI
▶︎
LACHC’S HIV HISTORY
▶︎
STAMPEDE: Abiraterone results (Short version)
▶︎
A future with No Prostate Biopsies with Mark Emberton, MD EP 86
▶︎
Gleason 3+4 vs 4+3: Which One Is More Dangerous?
▶︎
Hormonal Therapy for Prostate Cancer
▶︎
"Abiraterone saved my life." | Alfred's prostate cancer story
▶︎
3 Reasons Radiation Treatment May Not Be Your Best Option
▶︎
4 weeks post Prostatectomy
▶︎
Stop Blind Biopsies: Near-Perfect Prostate Cancer Accuracy with Dr. Mark Emberton - EP 170
▶︎
Gleason Score 6 7 8 9: Where You Sit on the Ladder Matters
▶︎
Don't Biopsy Your Prostate Until You Hear This (Part 2)
▶︎
Does #ProstateCancer Tumor Size and Location Matter? | #MarkScholzMD #AlexScholz | #PCRI
▶︎
Metastatic Prostate Cancer: What It Really Means (Not What You Think)
▶︎
Gleason 7 (4+3) #prostatecancer Treatments and Side Effects | #markscholzmd | PCRI
▶︎
Prostatakrebs: Neue Therapien, neue Perspektiven – Updates aus der Onkologie
▶︎
Thousands of men missing out on prostate cancer drug - BBC News
▶︎
Prostate Cancer Cure Explained: PSA, Recurrence, and Survival
▶︎